Ono Pharmaceutical Co., Ltd. (FRA:ON4)

Germany · Delayed Price · Currency is EUR

13.60

-0.10 (-0.73%)

At close: Feb 20, 2026

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceutical Business	486.87B	502.67B	447.19B	361.36B	309.28B
Pharmaceutical Business Growth	-3.14%	12.41%	23.75%	16.84%	5.77%
Total	486.87B	502.67B	447.19B	361.36B	309.28B
Total Growth	-3.14%	12.41%	23.75%	16.84%	5.77%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Japan	295.25B	308.23B	288.16B	241.97B	212.87B
Japan Growth	-4.21%	6.97%	19.09%	13.67%	4.93%
USA	167.05B	158.93B	142.79B	105.89B	85.57B
USA Growth	5.11%	11.30%	34.85%	23.75%	4.93%
Asia	16.34B	21.93B	11.63B	8.90B	7.45B
Asia Growth	-25.46%	88.61%	30.69%	19.46%	-0.47%
Europe	7.50B	13.59B	4.62B	4.61B	3.41B
Europe Growth	-44.77%	194.30%	0.24%	35.16%	545.27%
Others	729.00M	-	-	-	-
Total	486.87B	502.67B	447.19B	361.36B	309.28B
Total Growth	-3.14%	12.41%	23.75%	16.84%	5.77%

Source: S&P Global Market Intelligence.